Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveHarmony Biosciences Announces Planned CEO Transition

Live News EQUITY FLASH L impact Oct 12, 2026, 11:00 AM UTC

Harmony Biosciences Announces Planned CEO Transition

Harmony Biosciences announced a planned CEO transition.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

HRMY

Related stories

Merck-Moderna Vaccine Cuts Melanoma Death or Recurrence Risk 42% Trial data show the mRNA vaccine, combined with a widely used immunotherapy, cut melanoma disease-spread risk by 38%. M impact | EQUITY | Oct 22, 2026, 06:25 PM UTC Musk Reportedly Invests About $1 Billion in Skydance Elon Musk reportedly invested about $1 billion in Skydance, providing fresh capital as the entertainment company seeks to cut costs and support its share price after a costly merge M impact | EQUITY | Oct 22, 2026, 06:25 PM UTC Hitachi Energy to Invest $77 Million in New Brazil Plant Hitachi Energy will build a Brazil plant to produce power-transformer components, the company said. The investment is aimed at expanding supplies of equipment for power infrastruct M impact | EQUITY | Oct 22, 2026, 06:25 PM UTC XTI Aerospace Reports Preliminary Q3 Revenue of $35.3 Million The unaudited third-quarter 2026 revenue figure is in line with the company’s full-year outlook of $125 million to $130 million and remains subject to quarter-end closing procedure M impact | EQUITY | Oct 22, 2026, 06:13 PM UTC Nasdaq Reports Third-Quarter 2026 Revenue of $2.39 Billion Nasdaq said revenue rose 20.9% year over year to $2.39 billion. Net income attributable to Nasdaq increased 27.8% to $540 million, and diluted EPS rose 31.3% to $0.96. M impact | EQUITY | Oct 22, 2026, 06:12 PM UTC Moderna Shares Plunge Around 25% After Cancer-Vaccine Data Leak Details from a closely guarded mRNA-based cancer-vaccine study were shared on social media. Moderna shares fell around 25%, putting the stock on pace for its largest decline since M impact | EQUITY | Oct 22, 2026, 06:09 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.